Study Objectives: A baseline/1-hour rule-in/rule-out acute myocardial infarction (AMI) algorithm using cardiac troponin T Generation 5 (cTnT Gen 5) measurements is detailed in the 2015 European Society of Cardiology (ESC) non-ST-elevation myocardial infarction (NSTEMI) guidelines. The accuracy of the positive and negative predictive values for diagnostic testing plays a key role in physician therapeutic decisionmaking, especially for acutely ill patients.
To determine the ESC recommended baseline/1 hour AMI rule-in (hs-cTnT at 0-hour > 52 or a 1-hour delta 5 ng/L) positive predictive value (PPV) in the REACTION-US (Rapid evaluation of acute myocardial infarction in the United States) study and to compare it to that reported in the TRAPID-AMI (High sensitivity cardiac troponin T assay for rapid rule-out of acute myocardial infraction) international multicenter trial.
Methods: Patients presenting with any symptoms, regardless of duration, suspicious for an acute coronary syndrome (ACS) to the emergency department (ED) of a single US tertiary care urban center were enrolled. Baseline (within 60 minutes of triage ECG) and 1-hour blood samples were obtained and later analyzed for cTnT Gen 5 (Roche Diagnostics: 99 th percentile 14 ng/L, level of detection 5 ng/L) measurements at an independent core laboratory. AMI diagnosis was independently adjudicated by 2 physicians after reviewing all available 30-day clinical data and the hospital's serial cardiac troponin I (Siemens: 99 th percentile 40 ng/L) levels over 3 hours in accordance with the 3 rd Universal Definition of AMI. Results: Of the 569 enrolled subjects 44 (7.7%) had AMI: 26 type 1 (59%) and 18 (41%) type 2. After analyzing the baseline/1-hour ESC rule-in algorithm in the 542 patients with cTnT Gen 5 values available at both times, 69 (12.7%) were placed in the AMI rule-in zone. The resulting 1-hour AMI rule-in PPV was 42.0% (95% CI: 30.2%-54.5%). In the TRAPID-AMI trial 184 (14.4%) patients were placed in the rule-in zone and with a 1-hour AMI rule-in PPV of 77.2% (95% CI: 70.4%-83.0%). The PPV for the 1-hour rule-in AMI was significantly lower (p < 0.001) in the US ED population.
Conclusions: The PPV was significantly lower when the ESC guidelines AMI 1-hour rule-in were applied to the REACTION-US study as compared to the TRAPID-AMI international trial. This was likely the result of broader troponin ordering and enrollment of some dialysis patients, which may have resulted in an increased overall number of elevated cTnT Gen 5 measurements. The current ESC 1-hour rule-in AMI guidelines PPVs are inadequate to initiate early NSTEMI therapy in US and international ED patients as many individuals will receive unnecessary anticoagulation/ additional cardiac testing. Further studies are needed to determine the optimal cut points/blood draw timing for a rapid AMI rule-in guideline resulting in higher PPVs.
Diagnostic Accuracy of Adding Copeptin to Cardiac Troponin for Non-ST-Elevation Myocardial Infarction: A Systematic Review and MetaAnalysis
Kim C, Lim T, Kim W, Shin H, Na S/Hanyang University, Seoul, Korea, Republic of; Hallym University, Seoul, Republic of Korea Study Objectives: This study aimed to determine the diagnostic accuracy of adding copeptin to cardiac troponin (cTn) on admission to the emergency department (ED) for non-ST elevation myocardial infarction (NSTEMI) compared to cTn alone.
Methods: A literature search of MEDLINE, EMBASE, and the Cochrane Library was performed (search date: April 13, 2018). Primary studies were included if they accurately reported on patients with symptoms suggestive of acute myocardial infarction and measured both cTn alone and cTn with copeptin upon admission to the ED. The patients with evidence of ST elevation myocardial infarction were excluded. To assess the risk of bias for the included studies, the QUADAS-2 tool was used.
Results: The study participants included a total of 7,998 patients from 14 observational studies. The addition of copeptin to cTn significantly improved the sensitivity (0. Conclusions: Adding copeptin to cTn improved the sensitivity and negative predictive value for the diagnosis of NSTEMI compared to cTn alone. Thus, adding copeptin to cTn might help to screen NSTEMI early upon admission to the ED.
